Capsular rupture and axillary lymph node micrometastasis in breast cancer: Therapeutic and prognostic implications
Bulletin du Cancer · 2025
DOI: 10.1016/j.bulcan.2025.05.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bulletin du Cancer, 2025. Verfasst von Marie David und 10 weiteren Autor:innen. Beteiligte Einrichtung: Centre Léon-Bérard, 28, rue Laennec, 69008 Lyon, France. Electronic address: marie.david01@chu-lyon.fr. Hauptthemen laut MEDLINE: Breast Neoplasms, Neoplasm Micrometastasis, Lymphatic Metastasis, Lymph Nodes. Die Arbeit nennt 52 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: Capsular effraction in breast cancer with axillary lymph node metastasis is associated with higher non-sentinel lymph node metastasis when performing axillary dissection and worse outcome. Despite this, the presence of axillary micrometastasis no longer mandates additional axillary dissection due to their better prognosis. This study examines capsular effraction's specific impact in micrometastatic sentinel lymph nodes on non-sentinel lymph node involvement risk and overall prognosis. METHODS: A retrospective study was conducted in the Comprehensive Cancer Center Léon Bérard (Lyon, France), encompassing patients who underwent surgery between January 2005 and December 2015. The study evaluated the involvement of non-sentinel lymph nodes and examined overall survival, progression-free survival, and distant metastasis-free survival in groups with and without capsular rupture using univariable and multivariable Cox regression analyses. RESULTS: Among 146 patients, 101 (69.2%) had micrometastases without capsular rupture (RC- group), while 45 (30.8%) had micrometastases with capsular rupture (RC+ group). Among patients with lymph node involvement during axillary dissection, a higher proportion had≥2 involved micrometastasis nodes in the RC+ group (33.3%) compared to the RC- group (15.38%) but none had macrometastasis. However, no significant differences were found in overall survival, progression-free survival, or distant metastasis-free survival between the two groups. DISCUSSION: Capsular rupture in micrometastatic sentinel lymph nodes is associated with the presence of micrometastatic non-sentinel lymph node involvement but does not seem to impact overall survival and recurrence. Further studies are needed to explore the possible implications of capsular rupture in micrometastasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre Léon-Bérard, 28, rue Laennec, 69008 Lyon, France. Electronic address: marie.david01@chu-lyon.fr.
- Centre Léon-Bérard, 28, rue Laennec, 69008 Lyon, France.
- Centre Oscar-Lambret, 3, rue Frédéric Combemale, 59000 Lille, France.
Zitieren
APA
David, M., Jacquemin, J., Drouet, Y., Teyssier, M., Heinemann, M., Rossi, L., Faure, C., Klingler, S., Chopin, N., Lasset, C., & Mesdag, V. (2025). Capsular rupture and axillary lymph node micrometastasis in breast cancer: Therapeutic and prognostic implications. Bulletin du Cancer. https://doi.org/10.1016/j.bulcan.2025.05.005
Vancouver
David M, Jacquemin J, Drouet Y, Teyssier M, Heinemann M, Rossi L, et al. Capsular rupture and axillary lymph node micrometastasis in breast cancer: Therapeutic and prognostic implications. Bulletin du Cancer. 2025. doi:10.1016/j.bulcan.2025.05.005
BibTeX
@article{David2025,
author = {David, Marie and Jacquemin, Jérémie and Drouet, Youenn and Teyssier, Mélinda and Heinemann, Mellie and Rossi, Léa and Faure, Christelle and Klingler, Sophie and Chopin, Nicolas and Lasset, Christine and Mesdag, Violette},
title = {Capsular rupture and axillary lymph node micrometastasis in breast cancer: Therapeutic and prognostic implications},
journal = {Bulletin du Cancer},
year = {2025},
doi = {10.1016/j.bulcan.2025.05.005}
}
EUVIMED